Pneumology - Original Articles
19 June 2025
Early Access
https://doi.org/10.4081/monaldi.2025.3434

Impact of patient counseling on medication adherence and drug resistance patterns in tuberculosis patients

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Tuberculosis, adherence, counselling, patient education, non-adherence, treatment outcomes
0
Views
0
Downloads

Authors

Sanatkumar Bharamu Nyamagoud
https://orcid.org/0000-0002-5111-7685
Department of Pharmacy Practice, KLE College of Pharmacy, Vidyanagar, Hubballi, Karnataka, India.
Princy Domnic Dsouza
Department of Pharmacy Practice, KLE College of Pharmacy, Vidyanagar, Hubballi, Karnataka, India.
Sai Phalguna Prakash Chitralu
saiphalguna7@gmail.com
https://orcid.org/0009-0005-5612-703X
Department of Pharmacy Practice, KLE College of Pharmacy, Vidyanagar, Hubballi, Karnataka, India.
Kadambari Solankure
https://orcid.org/0000-0002-3740-6931
Department of Kriya Sharir, KAHER’S Shri B M Kankanwadi Ayurveda Mahavidyalaya, Shahapur, Belagavi, Karnataka, India.
Agadi Hiremath Viswanatha Swamy
Department of Pharmacy Practice, KLE College of Pharmacy, Vidyanagar, Hubballi, Karnataka, India.

Tuberculosis (TB) remains a primary global health concern, with non-adherence to anti-TB therapy contributing to prolonged infectiousness, treatment failure, and unfavorable outcomes. Despite established treatment protocols, adherence remains suboptimal due to patient-related, healthcare system, and socioeconomic barriers. This study aimed to identify key factors contributing to non-adherence and to evaluate the impact of structured patient counselling on treatment adherence. A cross-sectional observational study was conducted at Vivekananda General Hospital, Hubballi, India, involving 80 hospitalized TB patients. Data collection included demographic details and medication adherence scores, measured before and one month after counseling using the Medication Adherence Report Scale. Statistical analysis was performed using SPSS version 27.0, with Pearson’s correlation applied to assess changes in adherence. The mean adherence scores significantly increased from 4.24±1.452 to 7.05±1.525 following counseling (p=0.006). The most commonly reported barriers to adherence included forgetfulness (62.5%), limited access to healthcare (50%), and poor communication with healthcare providers (47.75%). These findings highlight the effectiveness of structured counseling in improving adherence among TB patients. Addressing both individual and systemic barriers through targeted counseling interventions should be considered an integral component of TB care strategies.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Munro SA, Lewin SA, Smith HJ, et al. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 2007;4:e238. DOI: https://doi.org/10.1371/journal.pmed.0040238
Alipanah N, Jarlsberg L, Miller C, et al. Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies. PLoS Med 2018;15:e1002595. DOI: https://doi.org/10.1371/journal.pmed.1002595
Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of Tuberculosis. Am J Respir Crit Care Med 2003;167:603-62. DOI: https://doi.org/10.1164/rccm.167.4.603
Lönnroth K, Styblo K, Jaramillo E, et al. Alcohol use as a risk factor for tuberculosis – a systematic review. BMC Public Health 2008;8:289. DOI: https://doi.org/10.1186/1471-2458-8-289
Fang XH, Shen HH, Hu WQ, et al. Prevalence of and factors influencing anti-tuberculosis treatment non-adherence among patients with pulmonary tuberculosis: a cross-sectional study in Anhui Province, Eastern China. Med Sci Monit 2019;25:1928-35. DOI: https://doi.org/10.12659/MSM.913510
Sen T, Joshi SR, Udwadia ZF, et al. Tuberculosis and diabetes mellitus: merging epidemics. J Assoc Physicians India 2009;57:399-404.
Pym AS, Diacon AH, Tang SJ, et al. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Eur Respir J 2016;47:564-74. DOI: https://doi.org/10.1183/13993003.00724-2015
Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2015;2015:CD003343. DOI: https://doi.org/10.1002/14651858.CD003343.pub4
Tesfahuneygn G, Medhin G, Legesse M, et al. Adherence to anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia. BMC Res Notes 2015;8:503. DOI: https://doi.org/10.1186/s13104-015-1452-x
Dameria D, Sjattar EL, Syam Y, et al. Improvement of patients’ knowledge, attitude, and practice on tuberculosis treatment using video and leaflet. J Promosi Kesehatan Indonesia 2023;18:79-88. DOI: https://doi.org/10.14710/jpki.18.2.79-88
Efendi S, Sjattar EL, Syam Y, et al. Health counseling support medication adherence to regular pulmonary tuberculosis patients. Clin Epidemiol Glob Health 2022;15:101055. DOI: https://doi.org/10.1016/j.cegh.2022.101055
Ngamvithayapong-Yanai J, Luangjina S, Nedsuwan S, et al. Implementing a community-based tuberculosis patient support intervention: a randomized controlled trial in northern Thailand. PLoS One 2019;14:e0220718.
Pai M, Minion J, Sohn H, et al. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med 2009;30:701-16. DOI: https://doi.org/10.1016/j.ccm.2009.08.016
World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017. Available from: https://iris.who.int/bitstream/handle/10665/255052/9789241550000-eng.pdf.
McLaren ZM, Milliken AA, Meyer AJ, et al. Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy. BMC Infect Dis 2016;16:537. DOI: https://doi.org/10.1186/s12879-016-1862-y
Lv H, Zhang X, Bai J, etal. Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019. BMC Infect Dis 2024;24:243. DOI: https://doi.org/10.1186/s12879-024-09079-5
Chandru BA, Varma RP. Factors affecting ability of TB patients to follow treatment guidelines – applying a capability approach. Int J Equity Health 2023;22:176. DOI: https://doi.org/10.1186/s12939-023-01991-7
Divala TH, Hoa NB, Simbar N, et al. Utility of broad-spectrum antibiotics for diagnosing pulmonary tuberculosis in adults: a systematic review and meta-analysis. Lancet Infect Dis 2020;20:1089-98. DOI: https://doi.org/10.1016/S1473-3099(20)30143-2
Saldanha N, Runwal K, Ghanekar C, et al. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India. BMC Infect Dis 2019;19:391. DOI: https://doi.org/10.1186/s12879-019-4042-z
Naidoo K, Perumal R, Ngema SL, et al. Rapid diagnosis of drug-resistant tuberculosis–opportunities and challenges. Pathogens. 2024;13:27. DOI: https://doi.org/10.3390/pathogens13010027
Nezenega ZS, Perimal-Lewis L, Maeder AJ, et al. Factors influencing patient adherence to tuberculosis treatment in Ethiopia: a literature review. Int J Environ Res Public Health 2020;17:5626. DOI: https://doi.org/10.3390/ijerph17155626

Ethics Approval

Ethical approval was granted by the KLE College of Pharmacy Ethical Committee (IEC Reference Number: KLECOPH/IEC/2023-24/08).

How to Cite



“Impact of Patient Counseling on Medication Adherence and Drug Resistance Patterns in Tuberculosis Patients”. 2025. Monaldi Archives for Chest Disease, June. https://doi.org/10.4081/monaldi.2025.3434.
Copyright (c) 2025 The Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.